UNITED THERAPEUTICS Corp — Director's Dealing 2021

Mar 17, 2021

SEC Form 4/A — Form 4/A

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2018-03-15

Reporting Person: EDGEMOND JAMES (CFO and Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-15	Stock Options	$111.00	A	75349	Acquired	2028-03-15	Common Stock (75349)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1229	Direct

Footnotes

F1: Includes 156 shares acquired on March 4, 2021 under the United Therapeutics Corporation Employee Stock Purchase Plan.

F2: These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profit margin during 2018-2020, which was determined on February 24, 2021. Number of stock options reported represents the number of options earned based on performance.

F3: This Form 4/A is being filed to correct the expiration date of this award.